LncRNA FENDRR Suppresses Melanoma Growth via Influencing c-Myc mRNA Level

References

• Kremenovic M, Schenk M, Lee DJ. Clinical and molecular insights into BCG immunotherapy for melanoma. J Intern Med. 2020;288:625–640. doi:10.1111/joim.13037
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Freddie B, Jacques F, Isabelle S, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;2018:254.
   Google Scholar
• Ross MI, Gershenwald JE. Evidence-based treatment of early-stage melanoma. J Surg Oncol. 2011;104(4):341–353. doi:10.1002/jso.21962
   PubMed Web of Science ®Google Scholar
• Beatriz D, José M, Lopes P, et al. Melanoma treatment in review. Immunotargets Ther. 2018;2018:178.
   Google Scholar
• Tagliaferri L, Lancellotta V, Fionda B, et al. Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review. Hum Vaccin Immunother. 2022;18(3):1903827. doi:10.1080/21645515.2021.1903827
   PubMed Web of Science ®Google Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17:47–62. doi:10.1038/nrg.2015.10
   PubMed Web of Science ®Google Scholar
• Deveson IW, Hardwick SA, Mercer TR, Mattick JS. The dimensions, dynamics, and relevance of the mammalian noncoding transcriptome. Trends Genet Tig. 2017;33:464. doi:10.1016/j.tig.2017.04.004
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Cao Q, Yang W, Ji X, Wang W. Long non-coding RNA ST8SIA6-AS1 promotes lung adenocarcinoma progression through sponging miR-125a-3p. Front Genet. 2020;11. doi:10.3389/fgene.2020.597795
   Web of Science ®Google Scholar
• Li M, Liang M, Lan T, Wu X, Peng B. Four immune-related long non-coding RNAs for prognosis prediction in patients with hepatocellular carcinoma. Front Mol Biosci. 2020;7. doi:10.3389/fmolb.2020.566491
   Web of Science ®Google Scholar
• Jia H, Wu D, Zhang Z, Li S. Regulatory effect of the MAFGAS1/miR1505p/MYB axis on the proliferation and migration of breast cancer cells. Int J Oncol. 2020;58(1):33–44. doi:10.3892/ijo.2020.5150
   PubMed Web of Science ®Google Scholar
• Wang S, Cheng M, Zheng X, Zheng L, Chen W. Interactions between lncRNA TUG1 and miR-9-5p modulate the resistance of breast cancer cells to doxorubicin by regulating eIF5A2. Onco Targets Ther. 2020;13:13159–13170. doi:10.2147/OTT.S255113
   PubMed Web of Science ®Google Scholar
• Dandan Y, Xiyi L, Jun S, et al. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non–small cell lung cancer cell proliferation by epigenetically repressing p21 expression. Mol Cancer. 2018;17(1):92. doi:10.1186/s12943-018-0836-7
   PubMedGoogle Scholar
• Zhang L, Yang ZH, Trottier J, Barbier O, Wang L. Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate Shp mRNA decay. Hepatology. 2017;65(2):604–615. doi:10.1002/hep.28882
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Li J-H, Liu S, Zhou H, Qu L-H, Yang J-H. starBase v2. 0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–D7. doi:10.1093/nar/gkt1248
   PubMed Web of Science ®Google Scholar
• Zhao W, Cui Y, Liu L, et al. METTL3 facilitates oral squamous cell carcinoma tumorigenesis by enhancing c-Myc stability via YTHDF1-mediated m(6)A modification. Mol Ther Nucleic Acids. 2020;20:1–12. doi:10.1016/j.omtn.2020.01.033
   PubMedGoogle Scholar
• Leucci E, Vendramin R, Spinazzi M, et al. Melanoma addiction to the long non-coding RNA SAMMSON. Nature. 2016;531(7595):518–+. doi:10.1038/nature17161
   PubMed Web of Science ®Google Scholar
• Xia Y, Zhou Y, Han H, Li P, Wei W, Lin NX. lncRNA NEAT1 facilitates melanoma cell proliferation, migration, and invasion via regulating miR-495-3p and E2F3. J Cell Physiol. 2019;234(11):19592–19601. doi:10.1002/jcp.28559
   PubMed Web of Science ®Google Scholar
• Han CF, Tang FJ, Chen J, et al. Knockdown of lncRNA-UCA1 inhibits the proliferation and migration of melanoma cells through modulating the miR-28-5p/HOXB3 axis. Exp Ther Med. 2019;17(5):4294–4302. doi:10.3892/etm.2019.7421
   PubMed Web of Science ®Google Scholar
• Luan W, Ding Y, Ma S, Ruan H, Wang J, Lu F. Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis. Cell Death Dis. 2019;10. doi:10.1038/s41419-019-2090-3
   Web of Science ®Google Scholar
• Li Y, Zhang W, Liu P, et al. Long non-coding RNA FENDRR inhibits cell proliferation and is associated with good prognosis in breast cancer. Onco Targets Ther. 2018;11:1403–1412. doi:10.2147/OTT.S149511
   PubMed Web of Science ®Google Scholar
• Qin X, Lu M, Zhou Y, Li G, Liu Z. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells. Cell Cycle. 2019;18(8):889–897. doi:10.1080/15384101.2019.1598726
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhang X, Wang L, et al. FENDRR suppresses cervical cancer proliferation and invasion by targeting miR-15a/b-5p and regulating TUBA1A expression. Cancer Cell Int. 2020;20(1). doi:10.1186/s12935-020-01223-w
   Web of Science ®Google Scholar